Publisher's Synopsis
For more than 50 years, Sleisenger & Fordtran's Gastrointestinal and Liver Disease has been the definitive reference for gastroenterology and hepatology physicians, students and trainees, and the broader multi-disciplinary GI care team. Now guided by a new generation of leaders in the field, this two-volume masterwork brings together the knowledge and expertise of hundreds of global experts who keep you up to date with all aspects of GI and liver disease-everything from basic science to new techniques and technologies--. A consistent organization, more than 1,100 full-color illustrations, and clinically practicable algorithms ensure quick access to updated and current information on the diagnosis, treatment, and management of gastrointestinal and liver diseases. The 12th edition welcomes a new senior editorial team of Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, and features many improvements and additions:
- New and expanded discussions of eosinophilic disorders, MASLD (metabolic dysfunction-associated steatotic liver disease, formerly known as non-alcoholic fatty liver disease); the use of AI in endoscopy for improved detection of GI cancers; new treatments for viral hepatitis and autoimmune liver diseases; the expanded array of new treatments for inflammatory bowel disorders; and more
- New chapters on Gastrointestinal and Hepatic Manifestations of Coronavirus Infection; Enterocolitis and Hepatitis Induced by Cancer Immunotherapy, and a new section on Neoplasia Involving Multiple Organs
- Reliable coverage of a wide range of endoscopic procedures for diagnosis and treatment, including balloon dilatation, stent placement/removal, and the management of small bowel angioectasia
- Quick-reference algorithms that summarize clinical decision making and practical approaches to patient management
- A consistent, templated format throughout the text that enables quick retrieval of information, and more than 20 videos of endoscopic procedures
- Any additional digital ancillary content may publish up to 6 weeks following the publication date
TBD at May 2022 planning meeting
